Samenvatting
Aims: Previously published diagnostic systems, based on ECG analysis and clinical parameters (Schwartz criteria and Keating criteria), have been used to estimate the probability of inherited long QT syndrome (LQTS). Nowadays, a certain diagnosis can often be made by DNA testing. We aimed to establish the predictive power of the Schwartz and Keating criteria, using DNA testing as a reference, and to determine the best diagnostic strategy. Methods and results: We studied 513 relatives (aged >10 years) of 77 consecutive LQTS probands with a known disease-causing mutation. The Schwartz criteria identified 'high probability of LQTS' (score ≥4) in 41 of 208 mutation carriers, yielding 19% sensitivity and 99% specificity. The Keating criteria had 36% sensitivity and 99% specificity. Alternatively, by analysing QTc duration alone, we found that 430 ms is the optimal cut-off value to distinguish carriers (≥430 ms) from non-carriers (
| Originele taal-2 | English |
|---|---|
| Pagina's (van-tot) | 575-580 |
| Aantal pagina's | 6 |
| Tijdschrift | European Heart Journal |
| Volume | 28 |
| Nummer van het tijdschrift | 5 |
| DOI's | |
| Status | Published - 1-mrt.-2007 |
Vingerafdruk
Duik in de onderzoeksthema's van 'Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: Do we need a scoring system?'. Samen vormen ze een unieke vingerafdruk.Citeer dit
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver